BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10776788)

  • 1. HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62.
    Chen YH; Xiao Y; Wu W; Wang Q; Luo G; Dierich MP
    Immunobiology; 2000 Jan; 201(3-4):317-22. PubMed ID: 10776788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins.
    Ebenbichler CF; Röder C; Vornhagen R; Ratner L; Dierich MP
    AIDS; 1993 Apr; 7(4):489-95. PubMed ID: 8507415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62.
    Chen YH; Xiao Y; Wu W; Yang J; Sui S; Dierich MP
    AIDS; 1999 Jun; 13(9):1021-4. PubMed ID: 10397530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interaction between C-domain on HIV-1 gp41 and the putative receptor protein p62.
    Yang H; Xiao Y; Lu Y; Chen YH
    Immunobiology; 2001 Aug; 203(5):778-85. PubMed ID: 11563677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-2 transmembrane protein gp36 like HIV-1 gp41 binds to human lymphocytes and monocytes.
    Chen YH; Christiansen A; Böck G; Dierich MP
    AIDS; 1995 Oct; 9(10):1193-4. PubMed ID: 8519457
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 gp41 by N-domain binds the potential receptor protein P45.
    Xiao Y; Wu W; Dierich MP; Chen Y
    Int Arch Allergy Immunol; 2000 Mar; 121(3):253-7. PubMed ID: 10729785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic characterization of HIV-1 gp41 binding proteins.
    Chen YH; Speth C; Wu W; Stockl G; Xiao Y; Yu T; Ke Z; Zhao Y; Dierich MP
    Immunol Lett; 1998 Jun; 62(2):75-9. PubMed ID: 9698101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of a short human immunodeficiency virus (HIV)-2 gp36 sequence into an HIV-1 p24 recombinant protein results in a polypeptide with potent and TCRBV-restricted T cell triggering activity.
    Imberti L; Sottini A; Quiròs Roldan E; Albertini A; Mattioli S; Prati E; Primi D
    Eur J Immunol; 1995 Jan; 25(1):218-25. PubMed ID: 7843234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human interferon-beta inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41.
    Yu T; Xiao Y; Bai Y; Ru Q; Luo G; Dierich MP; Chen Y
    Immunol Lett; 2000 Jul; 73(1):19-22. PubMed ID: 10963806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol-selective mechanism of HIV antigen conjugation with serum IgM, IgG, and IgA.
    Kostyushov VV
    Bull Exp Biol Med; 2000 Dec; 130(12):1147-9. PubMed ID: 11276306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
    Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
    AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation.
    Chen YH; Christiansen A; Dierich MP
    Immunol Lett; 1995 Nov; 48(1):39-44. PubMed ID: 8847089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.
    Chen YH; Wu W; Yang J; Sui SF; Sun J; Dierich MP
    Immunol Lett; 1999 Aug; 69(2):253-7. PubMed ID: 10482360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional solubilization of aggregation-prone HIV envelope proteins by covalent fusion with chaperone modules.
    Scholz C; Schaarschmidt P; Engel AM; Andres H; Schmitt U; Faatz E; Balbach J; Schmid FX
    J Mol Biol; 2005 Feb; 345(5):1229-41. PubMed ID: 15644217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.
    Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
    J Immunol; 1993 Dec; 151(11):6583-92. PubMed ID: 8245486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells.
    Hallenberger S; Moulard M; Sordel M; Klenk HD; Garten W
    J Virol; 1997 Feb; 71(2):1036-45. PubMed ID: 8995623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.